According to Zhitong Finance App News, Shengnuo Biotech (688117.SH) released its 2026 semi-annual performance forecast. It is expected to achieve net profit of 127 million yuan to 147 million yuan in the 2026 semi-year. Compared with the same period last year, it will increase 38.4573 million yuan to 57.638 million yuan, an increase of 43.23% to 64.79% over the previous year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.